Latest news
Supernus And Indivior To Merge And Create $2.2 Billion CNS Biopharmaceutical Company - Pulse 2.0Pulse 2.0 · Wed, 05 Aug 2026 16:41:40 GMTSupernus and Indivior Partner in 2 Billion CNS Biopharma Merger - sekbernews.idsekbernews.id · Tue, 04 Aug 2026 12:26:23 GMTSupernus & Indivior to merge in $2.2 billion CNS pharma deal - Voice of HealthcareVoice of Healthcare · Tue, 04 Aug 2026 06:09:03 GMTSupernus and Indivior merge to create CNS mega-company with 11 approved drugs - BioSpaceBioSpace · Mon, 03 Aug 2026 17:31:28 GMTSupernus (SUPN) And Indivior (INDV) Merge To Form $2.2 Billion CNS Pharmaceutical Giant - londoninsider.co.uklondoninsider.co.uk · Mon, 03 Aug 2026 16:16:07 GMTSupernus, Indivior merge to create CNS-focused company and expand BD opportunities - Fierce PharmaFierce Pharma · Mon, 03 Aug 2026 15:20:52 GMTSupernus and Indivior Combine to Build $2.2B CNS Biopharmaceutical Company - Tech TimesTech Times · Mon, 03 Aug 2026 15:10:27 GMTSupernus to Combine with Indivior To Form CNS Biopharmaceutical Leader with Potential $2 Billion in Revenue - BenzingaBenzinga · Mon, 03 Aug 2026 14:44:26 GMT